[12/30/22]
Posted on December 30, 2022 in Health Law News
Published by: Hall Render
Medicare payment policy changes established under the CMS CY 2023 Medicare Physician Fee Schedule (“MPFS”) Final Rule, issued on November 1, 2022, become effective January 1, 2023. Below is a high-level summary of significant changes established for 2023. Evaluation and Management (E/M) Visits Over the past several years, CMS engaged in efforts with the... READ MORE
Tags: E/M, Medicare, opioid, PHE, Split/Shared E/M Visits, Telehealth
[06/15/18]
Posted on June 15, 2018 in Federal Advocacy
Published by: Hall Render
Senate and House Work to Combat the Opioid Crisis On June 13, Energy and Commerce Committee Chairman Greg Walden (R-OR), Ways and Means Committee Chairman Kevin Brady (R-TX), Energy and Commerce Committee Ranking Member Frank Pallone, Jr. (D-NJ) and Ways and Means Committee Ranking Member Richard Neal (D-MA) introduced H.R. 6, the Substance Use-Disorder... READ MORE
Tags: 340B, Helping to End Addiction and Lessen Substance Abuse Disorders Act, opioid, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, This Week in Washington
[03/16/18]
Posted on March 16, 2018 in Federal Advocacy
Published by: Hall Render
Senate Committee Hearing Assesses 340B Program The Senate Health, Education, Labor and Pensions (“HELP”) Committee held a hearing this week to examine the 340B drug discount program as some stakeholders have urged lawmakers to scale back its reach. HELP Committee Chairman Lamar Alexander (R-TN) said the purpose of the hearing was to learn more... READ MORE
Tags: 340B Program, ALTO Act, Health Resources & Services Administration, HELP Committee, HRSA, opioid, POWER Act, right-to-try, This Week in Washington
[03/05/18]
Posted on March 5, 2018 in Health Law News
Published by: Hall Render
On Tuesday, February 27, 2018, Attorney General Jeff Sessions announced the creation of the U.S. Department of Justice (“DOJ”) Prescription Interdiction & Litigation (“PIL”) Task Force in an ongoing effort to curb the country’s current prescription opioid crisis. According to DOJ’s press release, the PIL Task Force will “aggressively deploy and coordinate all available... READ MORE
Tags: New Prescription Interdiction & Litigation Task Force, opioid, OPPE, PDMP, PIL
